guidance, driving improvement, assessing

Contact Us | Glossary | Site Map | Links | Help | Accessibility | High Graphics |  Text Size: A |  A+ |  A++

Advanced Search

Publication Search Results

Dateascending datedescending date Publication Titleascending titledescending title TypeTopic
Aug-10 NICE (Multiple) Technology Appraisal Guidance No 195 – Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor NICE Guidance Arthritis
Aug-10 NICE (Multiple) Technology Appraisal Guidance No 199 – Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis (review of technology apraisal guidance 104 and 125) NICE Guidance Arthritis
Aug-10 NICE Interventional Procedures Guidance NICE Guidance Procedures
Aug-10 NICE Single Technology Appraisal Guidance No 196 – Imatinib for the adjuvant treatment of gastrointestinal stromal tumours NICE Guidance Cancer
Aug-10 NICE Single Technology Appraisal Guidance No 197 – Dronedarone for the treatment of non-permanent atrial fibrillation NICE Guidance General Medicine
Aug-10 NICE Single Technology Appraisal Guidance No 198 – Tocilizumab for the treatment of rheumatoid arthritis NICE Guidance Arthritis
Jul-10 NICE Single Technology Appraisal Guidance No 191 – Capecitabine for the treatment of advanced gastric cancer NICE Guidance General Medicine
Jul-10 NICE Single Technology Appraisal Guidance No 192 – Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer NICE Guidance Cancer
Jul-10 NICE Single Technology Appraisal Guidance No 193 – Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia NICE Guidance Cancer
Jul-10 NICE Single Technology Appraisal Guidance No194 – Denosumab for the treatment of therapy-induced bone loss in non-metastatic prostate cancer NICE Guidance Cancer
Jun-10 NICE Single Technology Appraisal Guidance No 190 – Pemetrexed for the maintenance treatment of non-small-cell lung cancer NICE Guidance Cancer
May-10 NICE (Multiple) Technology Appraisal Guidance No 188 – Human growth hormone (somatropin) for the treatment of growth failure in children (review of NICE technology appraisal guidance 42). NICE Guidance General Medicine
May-10 NICE Single Technology Appraisal Guidance No 189 – Sorafenib for the treatment of advanced hepatocellular carcinoma NICE Guidance General Medicine
May-10 NICE (Multiple) Technology Appraisal Guidance No 187 – Infliximab (review) and adalimumab for the treatment of Crohn’s disease (including a review of technology appraisal guidance 40). NICE Guidance General Medicine
Feb-10 NICE Single Technology Appraisal Guidance No 185 – Trabectedin for the treatment of advanced soft tissue sarcoma NICE Guidance Cancer
Feb-10 NICE Single Technology Appraisal Guidance No 186 – Certolizumab pegol for the treatment of rheumatoid arthritis NICE Guidance Arthritis
Feb-10 NICE Single Technology Appraisal Guidance No 180 – Ustekinumab for the treatment of adults withmoderate to severe psoriasis NICE Guidance Skin
Nov-09 NICE (Multiple) Technology Appraisal Guidance No 184 – Topotecan for the treatment of relapsed small-cell lung cancer NICE Guidance Cancer
Nov-09 NICE (Single) Technology Appraisal Guidance No 129: Bortezomib monotherapy for relapsed multiple myeloma NICE Guidance Cancer
Oct-09 NICE Single Technology Appraisal Guidance No 182 – Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention NICE Guidance Cardiovascular
Oct-09 NICE Single Technology Appraisal Guidance No 183 – Topotecan for the treatment of recurrent and stage IVB cervical cancer NICE Guidance Cancer
Sep-09 NICE (Multiple) Technology Appraisal Guidance No 155 – Ranibizumab and Pegaptanib for Age-related Macular Degeneration NICE Guidance General Medicine
Sep-09 NICE Single Technology Appraisal Guidance No 179 – Sunitinib for the treatment of gastrointestinal stromal tumours NICE Guidance Cancer
Sep-09 NICE Single Technology Appraisal Guidance No 181 – Pemetrexed for the first-line treatment of non-small-cell lung cancer NICE Guidance Cancer
Aug-09 NICE (Multiple) Technology Appraisal Guidance No 178 - Renal Cell Carcinoma NICE Guidance Cancer
Aug-09 NICE Single Technology Appraisal Guidance No 177 – Alitretinoin for the treatment of severe chronic hand eczema NICE Guidance General Medicine
Aug-09 NICE Single Technology Appraisal Guidance No 176 – Cetuximab for the first-line treatment of metastatic colorectal cancer NICE Guidance General Medicine
Cancer
Jul-09 NICE Single Technology Appraisal Guidance No 175 – Gefitinib for the second-line treatment of locally advanced or metastatic non-small-cell lung cancer (terminated appraisal) NICE Guidance Cancer
Jul-09 NICE Single Technology Appraisal Guidance No 173 – Tenofovir disoproxil for the treatment of chronic hepatitis B NICE Guidance General Medicine
Jul-09 NICE Single Technology Appraisal Guidance No 174 – Rituximab for the first-line treatment of chronic lymphocytic leukaemia NICE Guidance General Medicine
Jun-09 NICE Single Technology Appraisal Guidance No TA172 – Cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck NICE Guidance Cancer
Jun-09 NICE Single Technology Appraisal Guidance No 171 – Lenalidomide for the treatment of multiple myeloma in people who have received at least one prior therapy NICE Guidance General Medicine
Apr-09 NICE Single Technology Appraisal Guidance No170 – Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults NICE Guidance General Medicine
Mar-09 NICE (Multiple) Technology Appraisal Guidance No 169– Sunitinib for the first line treatment of advanced and/or metastatic renal cell carcinoma NICE Guidance Cancer
Feb-09 NICE (Multiple) Technology Appraisal Guidance No 168 - Amantadine, oseltamivir and zanamivir for the treatment of influenza (review of NICE technology appraisal guidance No. 58) NICE Guidance General Medicine
Feb-09 NICE (Multiple) Technology Appraisal Guidance No 167 – Endovascular stent-grafts for the treatment of abdominal aortic aneurysms. NICE Guidance Procedures
Jan-09 NICE (Multiple) Technology Appraisal Guidance No 166 - Cochlear implants for children and adults with severe to profound deafness NICE Guidance Procedures
Jan-09 NICE (Multiple) Technology Appraisal Guidance No 165 – Machine perfusion systems and cold static storage of kidneys from deceased donors NICE Guidance Procedures
Dec-08 NICE Single Technology Appraisal Guidance No 163 – Infliximab for acute exacerbations of ulcerative colitis NICE Guidance General Medicine
Dec-08 NICE Single Technology Appraisal Guidance No 164 – Febuxostat for the management of hyperuricaemia in people with gout NICE Guidance General Medicine
Nov-08 NICE Single Technology Appraisal Guidance No162 NICE Guidance Cancer
Oct-08 NICE (Multiple) Technology Appraisal Guidance No 159 NICE Guidance Procedures
Oct-08 NICE (Multiple) Technology Appraisal Guidance No 160 NICE Guidance General Medicine
Oct-08 NICE (Multiple) Technology Appraisal Guidance No 161 NICE Guidance General Medicine
Sep-08 NICE (Multiple) Technology Appraisal Guidance No 158 - Oseltamivir, amantadine and zanamivir for the prophylaxis of influenza (including a review of NICE technology appraisal guidance 67). NICE Guidance General Medicine
Sep-08 NICE Single Technology Appraisal Guidance No 157- Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults NICE Guidance Vascular Services
Aug-08 NICE (Multiple) Technology Appraisal Guidance No 156 – Routine antenatal anti-D prophylaxis for women who are rhesus D negative (Review of NICE technology appraisal guidance 41) NICE Guidance Blood
Maternity Services
Women's Health
Aug-08 NICE Single Technology Appraisal Guidance No 153 - Entecavir for the treatment of chronic hepatitis B NICE Guidance General Medicine
Aug-08 NICE Single Technology Appraisal Guidance No 154 - Telbivudine for the treatment of chronic hepatitis B NICE Guidance General Medicine
Jul-08 NICE (Multiple) Technology Appraisal Guidance No 152 NICE Guidance Cardiovascular
Jul-08 NICE (Multiple) Technology Appraisal Guidance No 151 NICE Guidance Diabetes
Jun-08 NICE Single Technology Appraisal Guidance No 144 Rimonabant for the treatment of overweight and obese adults NICE Guidance Obesity
Jun-08 NICE Single Technology Appraisal Guidance No 145 NICE Guidance Cancer
Jun-08 NICE Single Technology Appraisal Guidance No 146 NICE Guidance Skin
May-08 NICE (Multiple) Technology Appraisal Guidance No 142 – Epoetin alfa, epoetin beta and darbepoetin alfa for cancer treatment-induced anaemia NICE Guidance Blood
Cancer
May-08 NICE (Multiple) Technology Appraisal Guidance No 143 NICE Guidance General Medicine
Apr-08 NICE Single Technology Apprasial Guidance 140 and 141 NICE Guidance Arthritis
Mar-08 NICE (Multiple) Technology Appraisal Guidance No 139 NICE Guidance Procedures
Mar-08 NICE (Multiple) Technology Appraisal Guidance No 138 NICE Guidance Asthma
Feb-08 NICE (Multiple) Technology Appraisal Guidance 136 - Structural neuroimaging in first-episode psychosis NICE Guidance Mental Health
Feb-08 NICE Single Technology Appraisal Guidance No 137- Rituximab NICE Guidance Cancer
Jan-08 NICE (Multiple) Technology Appraisal Guidance No 135 Pemetrexed for the treatment of malignant pleural mesothelioma NICE Guidance Cancer
Jan-08 NICE (Single) Technology Appraisal Guidance No 134 Infliximab for the treatment of adults with psoriasis NICE Guidance Skin
Dec-07 Nice (Multiple) Technology Appraisal Guidance No: 131 and No: 132 NICE Guidance Children's Health
Asthma
Nutritional Care
Nov-07 NICE (Single) Technology Appraisal Guidance No 133 – Omalizumab for severe persistent allergic asthma NICE Guidance Asthma
Oct-07 NICE (Multiple) Technology Appraisal Guidance No 130: Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis. NICE Guidance Arthritis
Sep-07 NICE (Multiple) Technology Appraisal Guidance No 128 Stapled Haemorrhoidopexy for the treatment of haemorrhoids NICE Guidance Procedures
Sep-07 NICE (Multiple) Technology Appraisal Guidance No 111 (amended 2007) NICE Guidance Mental Health
Aug-07 NICE (Single) Technology Appraisal Guidance No 124: Pemetrexed for the treatment of non-small cell lung cancer NICE Guidance Cancer
Aug-07 NICE (Single) Technology Appraisal Guidance 125: Adalimumab for the treatment of psoriatic arthritis NICE Guidance Skin
Aug-07 NICE (Single) Technology Appraisal Guidance 126: Ritixumab for the treatment of rheumatoid arthritis NICE Guidance
Aug-07 NICE (Single) Technology Appraisal Guidance 127: Natalizumab for the treatment of adults with highly active relapsing-remitting multiple sclerosis NICE Guidance
Jul-07 NICE (Single) Technology Appraisal Guidance 123: Varenicline for smoking cessation NICE Guidance Substance Misuse
Jun-07 NICE (Multiple) Technology Appraisal Guidance No 121 Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma NICE Guidance Neurological services
Jun-07 NICE (Single) Technology Appraisal Guidance No 122: Alteplase for the treatment of acute ischaemic stroke NICE Guidance Stroke
May-07 NICE (Multiple) TAG 120 Cardiac resynchronisation (biventricular pacing) therapy for the treatment of heart failure NICE Guidance Cardiovascular
Mar-07 NICE (Multiple) Technology Appraisal Guidance No 80 Clopidogrel in the treatment of non-ST-segment-elevation acute coronary syndrome March 2007 Update NICE Guidance Cardiovascular
Feb-07 NICE (Single) Technology Appraisal Guidance No 119: Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia NICE Guidance Cancer
Jan-07 NICE (Multiple) Technology Appraisal Guidance No 114 Methadone and buprenorphine for the management of opioid dependence NICE Guidance Substance Misuse
Jan-07 NICE (Multiple) Technology Appraisal Guidance No 115 Naltrexone for the management of opioid dependence NICE Guidance Substance Misuse
Jan-07 NICE (Multiple) Technology Appraisal Guidance No 117 Cinacalcet hydrochloride for the treatment of secondary hyperparathyroidism NICE Guidance Renal
Jan-07 NICE (Multiple) Technology Appraisal Guidance No 118 Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer NICE Guidance Cancer
Jan-07 NICE (Single) Technology Appraisal Guidance No 116 Gemcitabine for the treatment of metastatic breast cancer NICE Guidance Cancer
Dec-06 NICE Technology Appraisal Guidance No 113 - Inhaled Insulin for the Treatment of Diabetes (Types 1 and 2) NICE Guidance Diabetes
Nov-06 NICE Technology Appraisal Guidance No 111 Donepezil, galantamine and rivastigmine (review) and memantine for the treatment of Alzheimer s disease NICE Guidance Mental Health
Nov-06 NICE Technology Appraisal Guidance No 112 Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer NICE Guidance Cancer
Sep-06 NICE Single Technology Appraisal No 109: Docetaxel for the adjuvant treatment of early node-positive breast cancer NICE Guidance Cancer
Sep-06 NICE Single Technology Appraisal No108: Paclitaxel for the adjuvant treatment of early node-positive breast cancer NICE Guidance Cancer
Aug-06 NICE Technology Appraisal Guidance 106 Peginterferon alfa and ribavarin for mild chronic hepatitis C NICE Guidance General Medicine
Aug-06 NICE Technology Appraisal Guidance No 105 - Laparoscopic surgery for colorectal cancer NICE Guidance Cancer
Jul-06 NICE Technology Appraisal Guidance No 103 Etanercept and efalizumab for adults with psoriasis NICE Guidance Skin
Jul-06 NICE Technology Appraisal Guidance No 104 Etanercept and infliximab for psoriatic arthritis NICE Guidance Arthritis
Jul-06 NICE Technology Appraisal Guidance No 102 Children with conduct disorders NICE Guidance Children's Health
Mental Health
Jun-06 NICE Technology Appraisal Guidance No 101 - Docetaxel for the treatment of hormone-refractory metastatic prostate cancer NICE Guidance Cancer
Apr-06 NICE Guidance 100 Oxaliplatin and capecitabine - adjuvant treatment of colorectal cancer NICE Guidance Cancer
Apr-06 NICE Technology Appraisal Guidance 99 Immunosuppressive therapy - renal transplantation in children NICE Guidance Children's Health
Renal
Mar-06 NICE Technology Appraisal Guidance No 98 Methylphenidate, atomoxetine and dexamfetamine NICE Guidance Children's Health
Feb-06 NICE Technology Appraisal Guidance No 97 Depression and anxiety computerised cognitive behaviour therapy (CCBT) NICE Guidance Mental Health
Feb-06 NICE Technology Appraisal Guidance No 96 - Hepatitis B (chronic) - adefovir dipivoxil and peginterferon alfa-2a NICE Guidance General Medicine
Jan-06 NICE Technology Appraisal Guidance No 95 - Implantable cardioverter defibrillators for arrhythmias NICE Guidance Cardiovascular
Aug-05 NICE Technology Appraisal Guidance No 93 - Colorectal cancer (advanced) - irinotecan, oxaliplatin and raltitrexed NICE Guidance Cancer
Jul-05 NICE Technology Appraisal Guidance No 92 HealOzone for tooth decay NICE Guidance Children's Health
Dentistry
May-05 Technology Appraisal Guidance 89 - The use of autologous chondrocyte implantation for the treatment of cartilage defects in knee joints NICE Guidance Procedures
May-05 NICE Technology Appraisal Guidance 90 - Clopidogrel and modified-release dipyridamole in the prevention of occlusive vascular events NICE Guidance General Medicine
Vascular Services
May-05 NICE Technology Appraisal Guidance 91 - Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer NICE Guidance Women's Health
Cancer
Feb-05 NICE Technology Appraisal Guidance No 88 - Dual-chamber pacemakers for the treatment of symptomatic bradycardia NICE Guidance Cardiovascular
Feb-05 NICE Technology Appraisal Guidance No 87 - Prevention of fragility fractures in postmenopausal women NICE Guidance General Medicine
Women's Health
Sep-04 NICE Technology Appraisal Guidance No 83 - Laparoscopic surgery for inguinal hernia repair NICE Guidance Procedures
Sep-04 NICE Technology Appraisal Guidance No 84 - The use of drotrecogin alfa (activated) for severe sepsis NICE Guidance General Medicine
Sep-04 NICE Technology Appraisal Guidance No 85 - Immunosuppressive therapy for renal transplantation in adults NICE Guidance Renal
Sep-04 NICE Technology Appraisal Guidance No 81 - Frequency of application of topical corticosteroids for atopic eczema NICE Guidance Skin
Sep-04 NICE Technology Appraisal Guidance No 82 - Tacrolimus and pimecrolimus for atopic eczema NICE Guidance Skin
Jul-04 NICE Technology Appraisal Guidance No 80 - Acute coronary syndromes - clopidogrel NICE Guidance Cardiovascular
May-04 NICE Technology Appraisal Guidance No 78 - Fluid-filled thermal balloon and microwave endometrial ablation techniques for heavy menstrual bleeding NICE Guidance Women's Health
May-04 NICE Technology Appraisal Guidance No 79 - Newer drugs for epilepsy in children NICE Guidance Children's Health
Epilepsy
Apr-04 NICE Technology Appraisal Guidance No 77 - Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia NICE Guidance General Medicine
Mar-04 NICE Guidance No. 76 - Newer drugs for epilepsy in adults NICE Guidance Epilepsy
Jan-04 NICE Technology Appraisal Guidance No 75 - interferon alfa (pegylated and non-peglated) and ribavirin for the treatment of chronic hepatitis C NICE Guidance General Medicine
Jan-04 NICE Technology Appraisal Guidance No 74 - pre-hospital initiation of fluid replacement therapy in trauma NICE Guidance Procedures
Nov-03 NICE Technology Appraisal Guidance No 72 - use of anakinra for rheumatoid arthritis NICE Guidance Children's Health
Arthritis
Nov-03 NICE Technology Appraisal Guidance No 73 - Myocardial perfusion scintigraphy NICE Guidance Procedures
Oct-03 NICE Technology Appraisal Guidance No 69 - the use of liquid based cytology for cervical screening NICE Guidance Screening
Oct-03 NICE Technology Appraisal Guidance No 70 - Use of imatinib for chronic myeloid leukaemia NICE Guidance Cancer
Oct-03 NICE Technology Appraisal Guidance No 71 - Use of coronary artery stents NICE Guidance Procedures
Sep-03 NICE Technology Appraisal Guidance No 68 - Photodynamic therapy for age-related macular degeneration NICE Guidance Older People's Health
Sep-03 NICE Technology Appraisal Guidance 65 - the use of rituximab for aggressive non-hodgkin's lymphoma NICE Guidance Cancer
Sep-03 NICE Technology Appraisal Guidance No 66 - the use of newer drugs for bipolar disorder NICE Guidance Mental Health
Aug-03 NICE Technology Appraisal Guidance 64 - use of somatropin in adults with growth hormone deficiency NICE Guidance General Medicine
Aug-03 NICE Technology Appraisal Guidance No 63 - use of glitazones for the treatment of type 2 diabetes NICE Guidance Diabetes
May-03 NICE Technology Appraisal Guidance 61 - use of treatments for colorectal cancer NICE Guidance Cancer
May-03 NICE Technology Appraisal Guidance No 62 - the use of capecitabine for breast cancer NICE Guidance Cancer
May-03 NICE Technology Appraisal Guidance 59 - Use of electroconvulsive therapy NICE Guidance Mental Health
May-03 NICE Technology Appraisal Guidance 60 - guidance on the use of patient-education models for diabetes NICE Guidance Diabetes
Feb-03 NICE Technology Appraisal Guidance 57 - use of continuous subcutaneous insulin infusion for diabetes NICE Guidance Diabetes
Feb-03 NICE Technology Appraisal Guidance 58 - use of zanamivir, oseltamivir and amantadine for the treatment of influenza NICE Guidance General Medicine
Feb-03 NICE Technology Appraisal Guidance No 56 - use of tension-free vaginal tape for stress incontinence NICE Guidance Women's Health
Dec-02 NICE Technology Appraisal Guidance No 53 - The use of long-acting insulin analogues for the treatment of diabetes - insulin glargine NICE Guidance Diabetes
Dec-02 NICE Technology Appraisal Guidance No 54 - The use of vinorelbine for the treatment of advanced breast cancer NICE Guidance Cancer
Oct-02 NICE Technology Appraisal Guidance No 51 - The use of computerised cognitive behaviour therapy for anxiety and depression NICE Guidance Mental Health
Oct-02 NICE Technology Appraisal Guidance No 52 - The use of drugs for early thrombolysis in the treatment of acute myocardial infarction NICE Guidance General Medicine
Sep-02 NICE Technology Appraisal Guidance - No. 47 Guidance on the use of glycoprotein IIb/IIIa inhibitors NICE Guidance Procedures
Sep-02 NICE Technology Appraisal Guidance - No. 49 Guidance on the use of ultrasonic locating devices for placing central venous catheter NICE Guidance Procedures
Sep-02 NICE Technology Appraisal Guidance No 50 - The use of imatinib for chronic myeloid leukaemia NICE Guidance Children's Health
Cancer
Sep-02 NICE Technology Appraisal Guidance No. 48 - Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure NICE Guidance Children's Health
Renal
Jul-02 NICE Technology Appraisal Guidance - No. 45 Guidance on the use of pegylated liposomal doxorubicin hydrochloride (PLDH) for the treatment of advanced ovarian cancer NICE Guidance Cancer
Jul-02 NICE Technology Appraisal Guidance - No. 46 Guidance on the use of surgery to aid weight reduction for people with morbid obesity NICE Guidance Children's Health
Jun-02 NICE Technology Appraisal Guidance - No. 44 Guidance on the use of metal-on-metal hip resurfacing arthroplasty NICE Guidance Procedures
Jun-02 NICE Technology Appraisal Guidance No 43 - Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia NICE Guidance Mental Health
May-02 NICE Technology Appraisal Guidance - No. 41 Guidance on the use of routine antenatal anti-D prophylaxis for RhD-negative women NICE Guidance Women's Health
May-02 NICE Technology Appraisal Guidance - No. 42 Guidance on the use of human growth hormone (somatropin) in children with growth failure NICE Guidance Children's Health
Apr-02 NICE Technology Appraisal Guidance - No. 40 Guidance on the use infliximab for Crohn's disease NICE Guidance General Medicine
Mar-02 NICE Technology Appraisal Guidance - No. 34 Guidance on the use of trastuzumab (Herceptin) for the treatment of advanced breast cancer NICE Guidance Cancer
Mar-02 NICE Technology Appraisal Guidance - No. 35 - Etanercept for the treatment of juvenile idiopathic arthritis NICE Guidance Children's Health
Arthritis
Mar-02 NICE Technology Appraisal Guidance - No. 36 Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis NICE Guidance Children's Health
Mar-02 NICE Technology Appraisal Guidance - No. 37 Guidance on the use of rituximab for recurrent or refractory Stage III or IV follicular non-Hodgkin's lymphoma NICE Guidance Cancer
Mar-02 NICE Technology Appraisal Guidance - No. 38 Inhaler devices for routine treatment of chronic asthma in older children (aged 5-15 years) NICE Guidance Children's Health
Asthma
Mar-02 NICE Technology Appraisal Guidance - No. 39 Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation NICE Guidance General Medicine
Procedures
Mar-02 NICE Technology Appraisal Guidance No. 33: Guidance on the use of irinotecan, oxaliplatin and raltitrexed for the treatmanet of advanced colorectal cancer NICE Guidance Cancer
Jan-02 NICE Technology Appraisal Guidance No 32: Beta interferons and glatiramer acetate for the treatment of multiple sclerosis NICE Guidance General Medicine
Oct-01 NICE Technology Appraisal Guidance - No. 31 - The use of sibutramine for the treatment of obesity NICE Guidance Obesity
Children's Health
Sep-01 NICE Technology Appraisal Guidance - No. 29: The use of fludarabine for B-cell chronic lymphocytic leukaemia NICE Guidance Cancer
Sep-01 NICE Technology Appraisal Guidance - No. 30: The use of taxanes for the treatment of breast cancer NICE Guidance Cancer
Aug-01 NICE Technology Appraisal Guidance - No. 28: Topotecan for the treatment of advanced ovarian cancer NICE Guidance Cancer
Aug-01 NICE Technology Appraisal Guidance 26 - use of docetaxel, paclitaxel, gemcitabine and vinorelbine for the treatment of non-small cell lung cancer NICE Guidance Cancer
Apr-01 NICE Technology Appraisal Guidance No 19 - donepezil, rivastigmine and galantamine for Alzheimer's disease NICE Guidance Older People's Health